After the recent European study confirming the cost-effectiveness of AI-based chest X-ray screening for osteoporosis, we are excited to share another milestone:

our US cost-effectiveness manuscript has now been published! (https://lnkd.in/dxMF5r_8)

Adding to this achievement, the study has also been featured in The Imaging Wire — highlighting its significance and impact within the medical imaging community.

This newly accepted study highlights that AI-driven opportunistic screening using routine chest radiographs is not only clinically impactful but also economically viable in the US healthcare context.

📌 Read more about the discussion here: https://lnkd.in/eUb4sjKQ

At Promedius, Osteo Signal continues to build momentum worldwide, supporting earlier osteoporosis detection, cost-effective screening, and better patient outcomes.

We extend our sincere thanks to Mickaël Hiligsmann, stuart silverman, and Jean-Yves REGINSTER 🌿 for their invaluable contributions to this important work.